Due to the dual roles of adiponectin in the pathogenesis of NAFLD and type 2 diabetes, adiponectin would represent a potential biomarker for the prediction of NAFLD and type 2 diabetes (35). The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.